For patients with STEMI secondary to spontaneous coronary artery dissection (SCAD), primary PCI can produce mortality and 30-day readmission rates similar to what’s seen in those treated for ...
The risk of dying over the next decade for STEMI patients who survive the first 90 days after primary PCI is just a few percentage points higher than people in the general population, an observational ...
Please provide your email address to receive an email when new articles are posted on . Addressing nonculprit lesions during primary PCI for STEMI was noninferior vs. a staged strategy. The trial was ...
LONDON — There appears to be no advantage for continuing anticoagulation treatment after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), according to ...
Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking ...
Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...
London, UK - The UK National Institute for Health and Clinical Excellence (NICE) has recommended the use of the anticoagulant bivalirudin (Angiox, the Medicines Company), in combination with aspirin ...
Amsterdam, Netherlands – 28 Aug 2023: Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary no-reflow phenomenon (NRP), a common adverse complication in patients with ST-segment elevation ...
LOS ANGELES—Baseline renal function is highly associated with worse 90-day outcomes among patients undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction ...
Please provide your email address to receive an email when new articles are posted on . A system of stand-alone chest pain units was established in a low-income, densely populated area. Patients ...
SAN FRANCISCO -- Pressure-controlled intermittent coronary sinus occlusion (PiCSO) for acute myocardial infarction (AMI) appeared safe but ineffective in reducing infarct size, the PiCSO-AMI-I trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback